25 March 2019

Amedeo Smart

Independent Medical Education

Subscriber: th..@boehringer-ingelheim.com

HIV Infection

25 March 2019 | n=39

  1. Li QH, Shao B, Li J, Wang JY, et al.
    Critical amino acid residues and potential N-linked glycosylation sites contribute to CRF01_AE pathogenesis in Northeast China.
    AIDS 2019.

  2. Sigel KM, Stone K, Wisnivesky JP, Park LS, et al.
    Short-term outcomes for lung cancer resection surgery in HIV infection.
    AIDS 2019.

  3. Reitsema M, Steffers L, Visser M, Heijne J, et al.
    Cost-effectiveness of increased hiv testing among men who have sex with men in the netherlands.
    AIDS 2019.

  4. Lau JSY, Smith MZ, Lewin SR, McMahon JH, et al.
    Clinical trials of antiretroviral treatment interruption in HIV-infected individuals.
    AIDS 2019;33:773-791.

  5. Whooley PD, Dorer RK, Kumar AS, Aboulafia DM, et al.
    HIV-associated anorectal Epstein-Barr virus-positive mucocutaneous ulcer successfully treated with liposomal doxorubicin and rituximab.
    AIDS 2019;33:929-930.

  6. Krusi A.
    Women incarceration and HIV: authors' reply.
    AIDS 2019;33:927-929.

  7. Nathan M.
    Letter to the editor re: women, incarceration and HIV.
    AIDS 2019;33:927.

  8. Sanders EJ, Chirro O, Oduor C, Mangi J, et al.
    Point-of-care HIV RNA testing and immediate antiretroviral therapy initiation in young adults seeking out-patient care in Kenya.
    AIDS 2019;33:923-926.

  9. Zanni MV, Grinspoon SK.
    Striving to characterize endocrine-metabolic and immune health risks among transgender women with HIV.
    AIDS 2019;33:919-922.

  10. Oldfield BJ, Munoz N, McGovern MP, Funaro M, et al.
    Integration of care for HIV and opioid use disorder.
    AIDS 2019;33:873-884.

  11. Coffey S, Bacchetti P, Sachdev D, Bacon O, et al.
    RAPID antiretroviral therapy: high virologic suppression rates with immediate antiretroviral therapy initiation in a vulnerable urban clinic population.
    AIDS 2019;33:825-832.

  12. Maurice JB, Garvey L, Tsochatzis EA, Wiltshire M, et al.
    Monocyte-macrophage activation is associated with nonalcoholic fatty liver disease and liver fibrosis in HIV monoinfection independently of the gut microbiome and bacterial translocation.
    AIDS 2019;33:805-814.

  13. Bull M, McKernan J, Styrchak S, Kraft K, et al.
    Phylogenetic analyses comparing HIV sequences from plasma at virologic failure to cervix vs. blood sequences from antecedent antiretroviral therapy suppression.
    AIDS Res Hum Retroviruses 2019.

  14. Portilla I, Reus S, Leon R, van-der Hofstad C, et al.
    Neurocognitive impairment in well controlled HIV-infected patients. A cross sectional study.
    AIDS Res Hum Retroviruses 2019.

  15. Edwar L, Karim B, Wijaya I, Ariyanto I, et al.
    Factors affecting the health of retinal vessels in HIV patients beginning anti-retroviral therapy.
    AIDS Res Hum Retroviruses 2019.

  16. Chen J, Huang Y, Hui Q, Mathur R, et al.
    Epigenetic Associations with Estimated Glomerular Filtration Rate (eGFR) among Men with HIV Infection.
    Clin Infect Dis 2019.

  17. Lanzafame M, Lattuada E, Vento S.
    DRIVE-AHEAD Trial's results and the need of a right comparator drug.
    Clin Infect Dis 2019.

  18. Tornheim JA, Starks AM, Rodwell TC, Gardy JL, et al.
    Building the framework for standardized clinical laboratory reporting of next generation sequencing data for resistance-associated mutations in Mycobacterium tuberculosis complex.
    Clin Infect Dis 2019.

  19. Gibbs A, Hatcher A, Jewkes R, Sikweyiya Y, et al.
    Associations between lifetime traumatic experiences and HIV-risk behaviours amongst young men living in informal settlements in South Africa: A cross-sectional analysis and structural equation model.
    J Acquir Immune Defic Syndr 2019.

  20. Rubin LH, Springer G, Martin EM, Seaberg EC, et al.
    Elevated depressive symptoms are a stronger predictor of executive dysfunction in HIV-infected women than men.
    J Acquir Immune Defic Syndr 2019.

  21. Phillips TK, Sinxadi P, Abrams EJ, Zerbe A, et al.
    A comparison of plasma efavirenz and tenofovir, dried blood spot tenofovir-diphosphate, and self-reported adherence to predict virologic suppression among South African women.
    J Acquir Immune Defic Syndr 2019.

  22. Relf MV, Pan W, Edmonds A, Ramirez C, et al.
    Discrimination, medical distrust, stigma, depressive symptoms, antiretroviral medication adherence, engagement in care and quality of life among women living with HIV in North Carolina: a mediated structural equation model.
    J Acquir Immune Defic Syndr 2019.

  23. Rothenberger M, Nganou-Makamdop K, Kityo C, Ssali F, et al.
    Impact of Integrase Inhibition compared to non-nucleoside inhibition on HIV reservoirs in Lymphoid Tissues.
    J Acquir Immune Defic Syndr 2019.

  24. Godfrey C, Bremer A, Alba D, Apovian C, et al.
    Obesity and Fat Metabolism in HIV-infected Individuals: Immunopathogenic Mechanisms and Clinical Implications.
    J Infect Dis 2019.

  25. Costantini S, Walensky RP.
    The Costs of Drugs in Infectious Diseases: Branded, Generics, and Why We Should Care.
    J Infect Dis 2019.

  26. Loiseau C, Requena M, Nayrac M, Mavigner M, et al.
    Increase of CXCR3+ T cells impairs Th17 cells recruitment in the small intestine mucosa through IFN-gamma and IL-18 during treated HIV-1 infection.
    J Infect Dis 2019.

  27. Lambert C, Batalie D, Montange T, Betsem E, et al.
    An immunodominant and conserved B-cell epitope in the envelope of simian foamy virus recognized by humans infected with zoonotic strains from apes.
    J Virol 2019.

  28. Heredia JD, Park J, Choi H, Gill KS, et al.
    Conformational engineering of HIV-1 Env based on mutational tolerance in the CD4 and PG16 bound states.
    J Virol 2019.

  29. Anand SP, Grover JR, Tolbert WD, Prevost J, et al.
    Antibody-induced internalization of HIV-1 Env proteins limits the surface expression of the closed conformation of Env.
    J Virol 2019.

  30. Zhuang M, Vassell R, Yuan C, Keller PW, et al.
    Mutations that increase the stability of the post-fusion gp41 conformation of the HIV-1 envelope glycoprotein are selected by both an X4 and R5 HIV-1 virus to escape fusion inhibitors corresponding to heptad repeat 1 of gp41, but the gp120 adaptive mu
    J Virol 2019.

  31. Boyer PL, Melody K, Smith SJ, Dunn LL, et al.
    Two Co-Selected Distal Mutations in HIV-1 Reverse Transcriptase (RT) Alter Susceptibility to Non-nucleoside RT Inhibitors and Nucleoside Analogs.
    J Virol 2019.

  32. Song YE, Olinger GY, Janaka SK, Johnson MC, et al.
    Sequence determinants in gammaretroviral Env cytoplasmic tails dictate virus-specific pseudotyping compatibility.
    J Virol 2019.

  33. Bollyky TJ, Templin T, Cohen M, Schoder D, et al.
    The relationships between democratic experience, adult health, and cause-specific mortality in 170 countries between 1980 and 2016: an observational analysis.
    Lancet 2019.

  34. Farnaes L, Coufal NG, Spector SA.
    Vaccine Strain Varicella Infection in an Infant With Previously Undiagnosed Perinatal Human Immunodeficiency Type-1 Infection.
    Pediatr Infect Dis J 2019;38:413-415.

  35. Trahan MJ, Lamarre V, Metras ME, Kakkar F, et al.
    Use of Triple Combination Antiretroviral Therapy With Raltegravir as Empiric HIV Therapy in the High-risk HIV-exposed Newborn.
    Pediatr Infect Dis J 2019;38:410-412.

  36. Hovis IW, Namuyonga J, Kisitu GP, Ndagire E, et al.
    Decreased Prevalence of Rheumatic Heart Disease Confirmed Among HIV-positive Youth.
    Pediatr Infect Dis J 2019;38:406-409.

  37. Patten G, Schomaker M, Davies MA, Rabie H, et al.
    What Should We Do When HIV-positive Children Fail First-line Combination Antiretroviral Therapy? A Comparison of 4 ART Management Strategies.
    Pediatr Infect Dis J 2019;38:400-405.

  38. Frigati L, Bekker A, Stroebele S, Goussard P, et al.
    Culture-confirmed Tuberculosis in South African Infants Younger Than 3 Months of Age: Clinical Presentation and Management of Respiratory Complications.
    Pediatr Infect Dis J 2019;38:351-354.

  39. Said K, Hella J, Ruzegea M, Solanki R, et al.
    Immunologic-based Diagnosis of Latent Tuberculosis Among Children Younger Than 5 Years of Age Exposed and Unexposed to Tuberculosis in Tanzania.
    Pediatr Infect Dis J 2019;38:333-339.

Display articles in

Amedeo HIV Infection

Data Origin

You selected the following journals for your Amedeo HIV Infection newsletter:

AIDS, AIDS Res Hum Retroviruses, Ann Intern Med, BMJ, Clin Infect Dis, J Acquir Immune Defic Syndr, J Clin Immunol, J Clin Invest, J Infect Dis, J Med Virol, J Virol, JAMA, Lancet, N Engl J Med, Nat Med, Pediatr Infect Dis J, Science, Virology.

To modify the journal selection, please open your Newsletter Management Page. If you don't remember the URL, please submit the email address of your Amedeo subscription.

Your email:

Amedeo HIV Infection

Five-Week Literature

25 May 2020

18 May 2020

11 May 2020

04 May 2020

28 April 2020

25 March 2019

Multidisciplinary Journal Club

  1. Nunn AJ, Phillips PPJ, Meredith SK, Chiang CY, et al.
    A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis.
    N Engl J Med. 2019 Mar 13. doi: 10.1056/NEJMoa1811867.

  2. Swindells S, Ramchandani R, Gupta A, Benson CA, et al.
    One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis.
    N Engl J Med. 2019;380:1001-1011.

  3. Wesson DE, Mathur V, Tangri N, Stasiv Y, et al.
    Veverimer versus placebo in patients with metabolic acidosis associated with chronic kidney disease: a multicentre, randomised, double-blind, controlled, phase 3 trial.
    Lancet. 2019 Mar 8. pii: S0140-6736(18)32562.

Every week, Amedeo's Multidisciplinary Journal Club (MJC) presents a selection of outstanding articles. Take a look beyond the horizon.

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016